Welcome to LookChem.com Sign In|Join Free

CAS

  • or

681836-70-4

Benzenamine, 5-methyl-N-(1-methylethyl)-2-nitro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

681836-70-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 681836-70-4 Structure

  • Basic information

    1. Product Name: Benzenamine, 5-methyl-N-(1-methylethyl)-2-nitro-
    2. Synonyms:
    3. CAS NO:681836-70-4
    4. Molecular Formula: C10H14N2O2
    5. Molecular Weight: 194.233
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 681836-70-4.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Benzenamine, 5-methyl-N-(1-methylethyl)-2-nitro-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Benzenamine, 5-methyl-N-(1-methylethyl)-2-nitro-(681836-70-4)
    11. EPA Substance Registry System: Benzenamine, 5-methyl-N-(1-methylethyl)-2-nitro-(681836-70-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 681836-70-4(Hazardous Substances Data)

681836-70-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 681836-70-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,1,8,3 and 6 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 681836-70:
(8*6)+(7*8)+(6*1)+(5*8)+(4*3)+(3*6)+(2*7)+(1*0)=194
194 % 10 = 4
So 681836-70-4 is a valid CAS Registry Number.

681836-70-4Relevant articles and documents

RXR-LXR heterodimer modulators for the potential treatment of dyslipidemia

Lagu, Bharat,Pio, Barbara,Lebedev, Rimma,Yang, Maria,Pelton, Patricia D.

, p. 3497 - 3503 (2007)

A number of RXR agonists were synthesized and screened in functional assays. The synthesis and the structure-activity relationship (SAR) within the series of compounds will be presented. Some in vivo data in rodent models for dyslipidemia and diabetes wil

Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

-

Page/Page column 29, (2010/11/26)

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.

BENZIMIDAZOLONE COMPOUNDS HAVING 5-HT4 RECEPTOR AGONISTIC ACTIVITY

-

Page/Page column 65, (2010/02/11)

This invention provides a compound of the formula (I) or a pharmaceutically acceptable salt thereof, and compositions containing such compounds and the use of such compounds for the manufacture of medicament for gastroesophageal reflux disease, gastrointe

2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety

-

Page/Page column 13, (2010/02/06)

This invention is directed to pyrimidine derivatives which are selective antagonists for the GalR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceuti

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 681836-70-4